Autoimmune Neuromuscular and Nerve Disorders Drug Development Summit
34 34 people viewed this event.
Over the past year, the Myasthenia Gravis landscape has transformed from a once-sparse market into a highly competitive, multi-billion-dollar arena, driven by breakthroughs in FcRn inhibition, complement targeting and B-cell modulation. Time: 9:00 am to 5:00 pm Prices: USD 2699.00 – USD 5297.00 Speakers: Jessica Van Baaren, Senior Scientist and Project Manager, Neuromuscular Translational Biology, UCB, Karen Lynch, Global Senior Director, Medical, Sanofi and more Venue details: Hotel AKA Back Bay, 154 Berkeley Street, Boston, Massachusetts, 02116, United States